|Basis of Allotment|
(This is only an advertisement for Information purposes and not a Prospectus announcement)
|INFINIUM PHARMACHEM LIMITED|
|The Corporate Identification Number of our Company is U24231GJ2003PLC043218|
Our Company was originally incorporated as "Infinium Pharmachem Private Limited" on 21st November, 2003 under the provisions of the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies. Ahmedabad. Gujarat. Later on, company was converted into public limited company, the name of our Company has changed to "Infinium Pharmachem Limited" and fresh Certificate of Incorporation dated August 12th, 2022 has been issued by the Registrar of Companies, Ahmedabad, Gujarat. Corporate Identification Number of our Company is U24231GJ2003PLC043218.
|Registered office: 38 G.I.D.C Sojitra, Taluka - Sojitra, Dist, - Anand, Gujarat - 387240,|
|Corporate Otlice: Suite 205, Sigma Prime, 2nd Floor, Nr. Sardar Patel Statue Vallabh Vidhyanagar, Dist. Anand - 388120, Gujarat.|
|Website: www.infiniumpharmachem.com. E-Mail: email@example.com, Telephone: +91 (2692) 238849,238850.|
|Company Secretary and Compliance Officer: Ms. Vrunda Harishbhai Patel;|
|PROMOTERS OF OUR COMPANY: MR. SANJAYKUMAR VITHTHALBHAI PATEL,|
|MR. PRAVIN BHADABHAI MADHANI AND MR. MITESH LAVJIBHAI CHIKHALIYA|
|BASIS OF ALLOTMENT SME IPO (NSE EMERGE)|
PUBLIC ISSUE OF UPTO 18,75,000 EQUITY SHARES OF FACE VALUE OF Rs.10/- EACH OF INFINIUM PHARMACHEM LIMITED ("INFINIUM" OR THE "COMPANY" OR THE "ISSUER") FOR CASH AT A PRICE OF Rs. 135/- PER EQUITY SHARE INCLUDING A SHARE PREMIUM OF Rs. 125/- PER EQUITY SHARE (THE "ISSUE PRICE") AGGREGATING TO Rs. 2,525.72 LAKHS ("THE ISSUE"), OUT OF WHICH 41,000 EQUITY SHARES OF FACE VALUE OF Rs. 10/- EACH FOR CASH AT A PRICE OF Rs. 121.50/-* EACH AGGREGATING TO ? 49.82 LAKHS WILL BE RESERVED FOR SUBSCRIPTION BY ELIGIBLE EMPLOYEES [OTHER THAN PROMOTER AND PROMOTER GROUP] OF THE ISSUER (THE "EMPLOYEES RESERVATION PORTION") AND 94,000 EQUITY SHARES OF FACE VALUE OF Rs. 10/- EACH FOR CASH AT A PRICE OF Rs. 135/- PER EQUITY SHARE INCLUDING A SHARE PREMIUM OF Rs. 125/- PER EQUITY SHARE AGGREGATING TO Rs. 126.90/- LAKHS WILL BE RESERVED FOR SUBSCRIPTION BY MARKET MAKER TO THE ISSUE (THE "MARKET MAKER RESERVATION PORTION"). THE ISSUE LESS THE ELIGIBLE EMPLOYEES RESERVATION AND MARKET MAKER RESERVATION PORTION i.e. NET ISSUE OF 17,40,000 EQUITY SHARES OF FACE VALUE OF Rs. 10/- EACH AT A PRICE OF Rs. 135/- PER EQUITY SHARE INCLUDING A SHARE PREMIUM OF Rs. 125/- PER EQUITY SHARE AGGREGATING TO Rs. 2,349.00 LAKHS IS HEREIN AFTER REFERRED TO AS THE "NET ISSUE". THE ISSUE AND THE NET ISSUE WILL CONSTITUTE 26.95% AND 25.01 % RESPECTIVELY OF THE POST ISSUE PAID UP EQUITY SHARE CAPITAL OF OUR COMPANY.
*Our Company in consultation with the Lead Manager, have ottered a discount of Rs. 13.50/- per Equity Share to Eligible Employees bidding in the Employee Reservation Portion.
In terms of the prospectus dated March 20th, 2023 and as per 253(2) of the SEBI (ICDR). Regulation, 2018 v/herein allocation in the net offer to the public category shall be; (a) minimum of 50% to Retail Individual Investors and (b) remaining to i) individual applicants other than retail individual investors and ii) other investors including corporate bodies or institutions, irrespective of number of specified securities applied for, provided that the unsubscribed portion in either of categories specified in clause (a) or (b) may be allocated to applicants in the other category.
Explanation: If the retail individual investor category is entitled to more than fifty percent, of the Net issue on a proportionate basis, the retail individual investors shall be allocated that higher percentage.
THE FACE VALUE OF THE EQUITY SHARES IS Rs. 10/- EACH AND THE ISSUE PRICE IS Rs. 135/- EACH INCLUDING A SHARE PREMIUM OF Rs. 125/- PER EQUITY SHARE THE ISSUE PRICE IS 13.50 TIMES OF THE FACE VALUE. THE ISSUE WAS OPENED ON FRIDAY. 31 ST MARCH, 2023 AND CLOSED ON WEDNESDAY, 05TH APRIL, 2023.
The Equity Shares offered through the Prospectus are proposed to be listed on the Emerge Platform of National Stock Exchange of India Limited ("NSE"). In terms of the Chapter IX of the SEBI (ICDR), Regulation, 2018, as amended from time to time, our company has received in-principle approval letter dated 17 TH March, 2023 from NSE for using its name in this offer document for listing of our shares on the Emerge Platform of NSE, For the purpose of this Issue, the Designated Stock Exchange will be the NSE Limited.
Details of Applications: The issue has received 2,007 applications (before Technical Rejection for 65 application of 90000 Equity Shares but after removing 1802 applications for 1875000 shares for which "bid filed but not banked) for 3525000 Equity Shares (including reserved portion of Market Maker of 94000 equity shares and Employee Reservation portion of 41000 equity shares) resulting 1.83 times subscription.
The details of the valid applications received in the issue (after Technical Rejections for 65 applications of 90000 Equity Shares but after removing 1802 applications for 1875000 Equity Shares for which "bid filed but not banked) are as follows:
|Category||Number 01 Applications||Number of Equity Shares||Subscription Ratio (After Revised Subscription)|
|Market Makers||1||94000||1.00 Times|
|Retail Individual Investors||1729||1729000||1.99 Times*|
|Otherthan Retail Individual Investors||197||1559000||1.79 Times*|
Total 29 applications for 29000 shares in Retail Individual Investors were rejected on technical grounds. Total 10 applications for 35000 shares in other than Retail Category were rejected on technical ground. Total 26 applications for 26000 shares in Employee Category were rejected on technical ground. Further, there was no withdrawal of application in any of the category.
*After revised subscription (original allocation was for 870000 Equity Shares and allotment was made for 915000 Equity Shares in retails category and in original Allocation was for 870000 Equity Shares and allotment was made for 825000 Equity Shares in otherthan retail category).
ALLOCATION: The Basis of Allotment was finalized in consultation with the Designated Stock Exchange being NSE Limited on 11th, April 2023.
A. Allocation to Market Maker (After Technical Rejections & Withdrawal): The Basis of Allotment to the Market Maker, at the issue price of Rs. 135/- per Equity Share, was finalized in consultation with NSE Limited. The category was subscribed by 1.00 times. The total number of shares allotted in this category is 94,000 Equity shares, out of reserved portion of 94.000 Equity Shares.
B. Allocation to Employee Reservation (After Technical Rejections & Withdrawal): The Basis of Allotment to the Employee Reservation, at the issue price of Rs. 121.50/- per Equity Share, was finalized in consultation with NSE Limited. The category was subscribed by 1.29 times. The total number of shares allotted in this category is 41,000 Equity shares, out of reserved portion of 41,000 Equity Shares.
C. Allocation to Retail Individual Investors (After Technical Rejections & Withdrawal, if any): The Basis of Allotment to the Retail Individual Investors, at the issue price of Rs. 135/- per Equity Share, was finalized in consultation with NSE Limited. The category was subscribed by 1.99 times (As per Revised Subscription). The total number of shares allotted in this category is 915000 Equity shares as under:
The category wise details of the Basis of Allotment are as under:
|No. of Shares Applied for (Category wise||No. of Applications received||% to total||Total No. ol Equity Shares applied in this Category||% of total||Proportionate Shares Available||Allocation per Applicant||Ratio of Allottes to Applicant||Serial Number of Qualifying applicants||Number ot Successful applicants (alter rounding off)||% to Total||Total No. of Equity Shares allocated/ allotted||% to Total||No. of Shares Surplus/ Deficit|
|Before Rounding off||After Rounding off|
Serial Number of Qualifying applications - Retail Individual Investors:
5,6,7,9,10,11,14,17,19,22,24,25,26,27,30,31,33.34.35,38.39.40,46.47,48,50,51,52.55,56,57,58,59,63,64,65.68,69.70,72,74,75.78,82.85.86, 87,88,89,94,95,96,99,102,106,109,111,113,114,116,119,120,122,123.124,125,127,129,133,135,140,142,143,144,145,148,150,152,155,157,158, 159,160,161.164,166,168,170,171,174,176,179,180,184,185,187,188,192,194,195.197,203,207,208,212,214,215,216,218,219,222.223.224,225, 226,227,228,229,230,234.235,18.104.22.168.241,242,243,245,246.248.249.250.251.252.253,256.258,261,263,264.266,267.269.270.271.272. 274,275,281,284,285,287,288
D. Allocation to Non-Retail Investors (Alter Technical Rejections & Withdrawal): The Basis of Allotment to the Non-Retail Individual Investors, at the issue price of Rs. 135/* per Equity Share, was finalized in consultation with NSE Limited. The category was subscribed by 1.79 times. Total number of shares allotted in this category is 825000- Equity Shares. The category wise basis of allotment is as under:
|No. of Shares Applied for (Category wise)||No. Of Applicat ions received||% to total||Total No. of Equity Shares applied in this Category||% of total||Proportio nate Shares Available||Allocation per Applicant||Ratio of Allottees to Applicant||Serial Number of Qualifying applicant||Humber of Successful applicants (after rounding||% to Total||Total No. of Equity Shares allocated/ allotted||% to Total||Surplus/ Deficit (Rounded- off)|
|(Before Rounding Off||(After Rounding Off)|
|0.00||0.00||1000||5||7||1,3,4, 6, 7||0.00||10000||1.21||10000|
The Board of Directors of the Company at its meeting held on 11th April, 2023 has taken on record the Basis of Allocation of Equity Shares approved by the Designated Stock Exchange viz. NSE and has authorized the corporate action for allotment of shares in dematerialized form to various successful applicants.
The allotment advise and/or notices are being dispatched to the address of the Applicants as registered with the depositories. Further the instructions to Self-Certified Syndicate Banks were being processed on or before 12th April, 2023. In case the same is not received within 10 days, investors may contact at the address given below. The Equity Shares allocated to successful applicants are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned. The Company is taking steps to get the Equity Shares admitted for trading on the Emerge Platform of NSE within Six working days from the date of the closure of the Issue. The trading is proposed to be commenced on Monday. 17th April, 2023 subject to receipt of final listing and trading approval from the NSE.
|INVESTORS PLEASE NOTE|
The details of the allotment made would also be hosted on the website of the Registrar to the issue, Bigshare Services Private Limited at www.bigshareonline.com. All future correspondence in this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/ Sole applicants, serial number of the Application Form, number of shares applied for and Bank Branch where the application had been lodged and payment details at the address of the Registrar given below:
|BIGSHARE SERVICES PRIVATE LIMITED|
|SEBI Registration Number: INR000001385|
|Address: Office No. S6 - 2.6th Floor, Pinnacle Business Park. Next to Ahura Centre, Mahakali Caves Road. Andheri - [East].|
|Mumbai-400093, Maharashtra. India.Tel. Number: +91 22 6263 8200: Fax- +91 22 6263 8299; Email Id: firstname.lastname@example.org|
|Investors Grievance Id: email@example.com; Website: www.bigshareonline.com; Contact Person: Mr. Swapnil Kate|
|On behalf of Board of Directors For INFINFINIUM PHARMACHEM LIMITED|
|Place: Anand||Mr. Sanjaykumar Viththalbhai Patel|
|Date: 13* April, 2023||Chairman and Managing Director DIN:00370715|
THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF INFINFINIUM PHARMACHEM LIMITED.
Note: All Capitalized terms used are not defined herein shall have the respective meanings assigned to them in the Prospectus.